Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10039-26-6
2. Lactose, Monohydrate
3. Lactose Hydrate
4. 64044-51-5
5. (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol;hydrate
6. Alpha-lactose,monohydrate
7. Lactose Standard 5 %
8. D-(+)-lactose 1-hydrate
9. Schembl927652
10. Dtxsid301016679
11. Akos015915778
12. (3r,4r,5s,6r)-6-(hydroxymethyl)-5-((2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)tetrahydro-2h-pyran-2,3,4-triol Hydrate
Molecular Weight | 360.31 g/mol |
---|---|
Molecular Formula | C12H24O12 |
Hydrogen Bond Donor Count | 9 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 4 |
Exact Mass | 360.12677620 g/mol |
Monoisotopic Mass | 360.12677620 g/mol |
Topological Polar Surface Area | 191 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 382 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34463
Submission : 2020-01-31
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15917
Submission : 2002-03-29
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17576
Submission : 2004-07-30
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17577
Submission : 2004-07-30
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21596
Submission : 2008-05-07
Status : Inactive
Type : IV
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Lactose Monohydrate API manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lactose Monohydrate API, including repackagers and relabelers. The FDA regulates Lactose Monohydrate API manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lactose Monohydrate API API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lactose Monohydrate API supplier is an individual or a company that provides Lactose Monohydrate API active pharmaceutical ingredient (API) or Lactose Monohydrate API finished formulations upon request. The Lactose Monohydrate API suppliers may include Lactose Monohydrate API API manufacturers, exporters, distributors and traders.
click here to find a list of Lactose Monohydrate API suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lactose Monohydrate API DMF (Drug Master File) is a document detailing the whole manufacturing process of Lactose Monohydrate API active pharmaceutical ingredient (API) in detail. Different forms of Lactose Monohydrate API DMFs exist exist since differing nations have different regulations, such as Lactose Monohydrate API USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lactose Monohydrate API DMF submitted to regulatory agencies in the US is known as a USDMF. Lactose Monohydrate API USDMF includes data on Lactose Monohydrate API's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lactose Monohydrate API USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lactose Monohydrate API suppliers with USDMF on PharmaCompass.
Lactose Monohydrate API Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lactose Monohydrate API GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lactose Monohydrate API GMP manufacturer or Lactose Monohydrate API GMP API supplier for your needs.
A Lactose Monohydrate API CoA (Certificate of Analysis) is a formal document that attests to Lactose Monohydrate API's compliance with Lactose Monohydrate API specifications and serves as a tool for batch-level quality control.
Lactose Monohydrate API CoA mostly includes findings from lab analyses of a specific batch. For each Lactose Monohydrate API CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lactose Monohydrate API may be tested according to a variety of international standards, such as European Pharmacopoeia (Lactose Monohydrate API EP), Lactose Monohydrate API JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lactose Monohydrate API USP).
LOOKING FOR A SUPPLIER?